T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Intel
INTC
|
+$1.59B |
| 2 |
Dollar General
DG
|
+$1.53B |
| 3 |
Charles Schwab
SCHW
|
+$1.19B |
| 4 |
Uber
UBER
|
+$971M |
| 5 |
Nike
NKE
|
+$868M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.83B |
| 2 |
Amazon
AMZN
|
+$2.33B |
| 3 |
NVIDIA
NVDA
|
+$1.75B |
| 4 |
Humana
HUM
|
+$1.46B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
Sector Composition
| 1 | Technology | 31.18% |
| 2 | Healthcare | 15.82% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Rimini Street
RMNI
$412M
| $163K | ﹤0.01% |
49,697
-12,373
| -20% | -$40.6K |
|
2602
The Joint Corp
JYNT
$161M
| $160K | ﹤0.01% |
16,627
| – | – |
|
2603
Phathom Pharmaceuticals
PHAT
$872M
| $159K | ﹤0.01% |
17,401
+4,007
| +30% | +$36.6K |
|
2604
Aldeyra Therapeutics
ALDX
$332M
| $158K | ﹤0.01% |
44,827
+4,935
| +12% | +$17.4K |
|
2605
Ranpak Holdings
PACK
$411M
| $158K | ﹤0.01% |
27,077
+496
| +2% | +$2.89K |
|
2606
The RealReal
REAL
$1.02B
| $158K | ﹤0.01% |
78,200
+1,500
| +2% | +$3.03K |
|
2607
ClearPoint Neuro
CLPT
$298M
| $157K | ﹤0.01% |
23,054
+688
| +3% | +$4.69K |
|
2608
Stoke Therapeutics
STOK
$1.22B
| $157K | ﹤0.01% |
29,789
| – | – |
|
|
LGF.A
2609
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $156K | ﹤0.01% |
14,226
+811
| +6% | +$8.89K |
|
2610
Lexicon Pharmaceuticals
LXRX
$392M
| $155K | ﹤0.01% |
100,691
| – | – |
|
|
SELF
2611
Global Self Storage
SELF
$57.9M
| $155K | ﹤0.01% |
33,399
| – | – |
|
|
IVAC
2612
DELISTED
Intevac Inc
IVAC
| $155K | ﹤0.01% |
35,846
+631
| +2% | +$2.73K |
|
2613
Marine Products Corp
MPX
$316M
| $154K | ﹤0.01% |
13,490
| – | – |
|
2614
Mural Oncology
MURA
$35.9M
| $154K | ﹤0.01% |
+25,992
| New | +$154K |
|
2615
Pangaea Logistics
PANL
$353M
| $154K | ﹤0.01% |
18,646
+417
| +2% | +$3.44K |
|
2616
nLIGHT
LASR
$1.43B
| $153K | ﹤0.01% |
+11,268
| New | +$153K |
|
2617
Horizon Bancorp
HBNC
$839M
| $152K | ﹤0.01% |
+10,598
| New | +$152K |
|
2618
RPC Inc
RES
$1.02B
| $152K | ﹤0.01% |
20,743
+1,546
| +8% | +$11.3K |
|
2619
Smith & Wesson
SWBI
$405M
| $152K | ﹤0.01% |
11,159
+852
| +8% | +$11.6K |
|
2620
Altimmune
ALT
$321M
| $151K | ﹤0.01% |
13,417
+3,370
| +34% | +$37.9K |
|
2621
Rigel Pharmaceuticals
RIGL
$670M
| $151K | ﹤0.01% |
10,393
+368
| +4% | +$5.35K |
|
2622
SIGA Technologies
SIGA
$622M
| $151K | ﹤0.01% |
26,962
+620
| +2% | +$3.47K |
|
2623
Select Water Solutions
WTTR
$928M
| $151K | ﹤0.01% |
19,851
+1,802
| +10% | +$13.7K |
|
2624
Arcutis Biotherapeutics
ARQT
$2.11B
| $149K | ﹤0.01% |
46,072
+23,125
| +101% | +$74.8K |
|
|
CFB
2625
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $149K | ﹤0.01% |
10,935
+608
| +6% | +$8.29K |
|